Interventionelle Radiologie Scan, Table of Contents Interventionelle Radiologie Scan 2013; 01(02): 143-162DOI: 10.1055/s-0033-1344333 Fortbildung © Georg Thieme Verlag KG Stuttgart · New YorkSelektive interne Radiotherapie – ein Update Thomas C. Lauenstein , Jens C. Altenbernd , Axel WetterRecommend Article Abstract Buy Article Full Text References Literatur 1 Ahmadzadehfar H, Biersack HJ, Ezziddin S. Radioembolization of liver tumors with yttrium-90 microspheres. Semin Nucl Med 2010; 40: 105-121 2 Salem R, Lewandowski RJ, Mulcahy MF et al. Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes. Gastroenterology 2010; 138: 52-64 3 Lewandowski RJ, Sato KT, Atassi B et al. Radioembolization with 90Y microspheres: angiographic and technical considerations. Cardiovasc Intervent Radiol 2007; 30: 571-592 4 Geschwind JF, Salem R, Carr BI et al. Yttrium-90 microspheres for the treatment of hepatocellular carcinoma. Gastroenterology 2004; 127: 194-S205 5 Antoch G, Mueller SP, Hamami M et al. Selective internal radiotherapy (SIRT) for hepatocellular carcinoma. Rofo 2010; 182: 660-670 6 Hilgard P, Muller S, Hamami M et al. Selective internal radiotherapy (radioembolization) and radiation therapy for HCC – current status and perspectives. Z Gastroenterol 2009; 47: 37-54 7 Memon K, Lewandowski RJ, Riaz A et al. Yttrium 90 microspheres for the treatment of hepatocellular carcinoma. Recent Results Cancer Res 2013; 190: 207-224 8 Willatt JM, Francis IR, Novelli PM et al. Interventional therapies for hepatocellular carcinoma. Cancer Imaging 2012; 12: 79-88 9 Song do S, Bae SH. Changes of guidelines diagnosing hepatocellular carcinoma during the last ten-year period. Clin Mol Hepatol 2012; 18: 258-267 10 Bowling JT, Reuter NP, Martin RC et al. Prior biliary tree instrumentation does not preclude hepatic arterial therapy for malignancy. Am Surg 2010; 76: 618-621 11 Park MJ, Kim YK, Lee MW et al. Small hepatocellular carcinomas: improved sensitivity by combining gadoxetic acid-enhanced and diffusion-weighted MR imaging patterns. Radiology 2012; 264: 761-770 12 Holzapfel K, Eiber MJ, Fingerle AA et al. Detection, classification, and characterization of focal liver lesions: value of diffusion-weighted MR imaging, gadoxetic acid-enhanced MR imaging and the combination of both methods. Abdom Imaging 2012; 37: 74-82 13 Memon K, Kulik L, Lewandowski RJ et al. Radioembolization for hepatocellular carcinoma with portal vein thrombosis: impact of liver function on systemic treatment options at disease progression. J Hepatol 2013; 58: 73-80 14 De Cecco CN, Ferrari R, Rengo M et al. Anatomic variations of the hepatic arteries in 250 patients studied with 64-row CT angiography. Eur Radiol 2009; 19: 2765-2770 15 Saba L, Mallarini G. Anatomic variations of arterial liver vascularization: an analysis by using MDCTA. Surg Radiol Anat 2011; 33: 559-568 16 Naymagon S, Warner RR, Patel K et al. Gastroduodenal ulceration associated with radioembolization for the treatment of hepatic tumors: an institutional experience and review of the literature. Dig Dis Sci 2010; 55: 2450-2458 17 Wallstabe I, Bakos G, Plotner A et al. Gastroduodenal ulceration after selective internal radiation therapy of liver tumor. Endoscopy 2012; 44 : E354-E355 18 Heusner TA, Hamami ME, Ertle J et al. Angiography-based C-arm CT for the assessment of extrahepatic shunting before radioembolization. Rofo 2010; 182: 603-608 19 Paprottka PM, Jakobs TF, Reiser MF et al. Practical vascular anatomy in the preparation of radioembolization. Cardiovasc Intervent Radiol 2012; 35: 454-462 20 Theysohn JM, Muller S, Schlaak JF et al. Selective internal radiotherapy (SIRT) of hepatic tumors: How to deal with the cystic artery. Cardiovasc Intervent Radiol 2012 Sept 15 [Epub ahead of print] 21 Bhalani SM, Lewandowski RJ. Radioembolization complicated by nontarget embolization to the falciform artery. Semin Intervent Radiol 2011; 28: 234-239 22 Leong QM, Lai HK, Lo RG et al. Radiation dermatitis following radioembolization for hepatocellular carcinoma: a case for prophylactic embolization of a patent falciform artery. J Vasc Interv Radiol 2009; 20: 833-836 23 Theysohn JM, Schlaak JF, Muller S et al. Selective internal radiation therapy of hepatocellular carcinoma: potential hepatopulmonary shunt reduction after sorafenib administration. J Vasc Interv Radiol 2012; 23: 949-952 24 Van de Wiele C, Maes A, Brugman E et al. SIRT of liver metastases: physiological and pathophysiological considerations. Eur J Nucl Med Mol Imaging 2012; 39: 1646-1655 25 Uliel L, Royal HD, Darcy MD et al. From the angio suite to the gamma-camera: vascular mapping and 99mTc-MAA hepatic perfusion imaging before liver radioembolization – a comprehensive pictorial review. J Nucl Med 2012; 53: 1736-1747 26 Riaz A, Lewandowski RJ, Kulik L et al. Yttrium-90 radioembolization using TheraSphere in the management of primary and secondary liver tumors. Q J Nucl Med Mol Imaging 2009; 53: 311-316 27 Van De Wiele C, Defreyne L, Peeters M et al. Yttrium-90 labelled resin microspheres for treatment of primary and secondary malignant liver tumors. Q J Nucl Med Mol Imaging 2009; 53: 317-324 28 Kritzinger J, Klass D, Ho S et al. Hepatic embolotherapy in interventional oncology: technology, techniques, and applications. Clin Radiol 2013; 68: 1-15 29 Memon K, Lewandowski RJ, Kulik L et al. Radioembolization for primary and metastatic liver cancer. Semin Radiat Oncol 2011; 21: 294-302 30 Salem R, Lewandowski RJ, Mulcahy MF et al. Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes. Gastroenterology 2010; 138: 52-64 31 Hilgard P, Hamami M, Fouly AE et al. Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival. Hepatology 2010; 52: 1741-1749 32 Vente MA, Wondergem M, van der Tweel I et al. Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis. Eur Radiol 2009; 19: 951-959 33 Salem R, Lewandowski RJ, Kulik L et al. Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma. Gastroenterology 2011; 140: 497-507 e2 34 Lewandowski RJ, Kulik LM, Riaz A et al. A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization. Am J Transplant 2009; 9: 1920-1928 35 Inarrairaegui M, Pardo F, Bilbao JI et al. Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma. Eur J Surg Oncol 2012; 38: 594-601 36 Kennedy AS, Dezarn WA, McNeillie P et al. Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients. Am J Clin Oncol 2008; 31: 271-279 37 Rhee TK, Lewandowski RJ, Liu DM et al. 90Y Radioembolization for metastatic neuroendocrine liver tumors: preliminary results from a multi-institutional experience. Ann Surg 2008; 247: 1029-1035 38 Damm R, Seidensticker R, Ricke J et al. Interventional radiological procedures in the therapy for colorectal liver metastases. Zentralbl Chir 2013; 138: 76-83 39 Seidensticker R, Denecke T, Kraus P et al. Matched-pair comparison of radioembolization plus best supportive care versus best supportive care alone for chemotherapy refractory liver-dominant colorectal metastases. Cardiovasc Intervent Radiol 2012; 35: 1066-1073 40 Kennedy AS, Coldwell D, Nutting C et al. Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience. Int J Radiat Oncol Biol Phys 2006; 65: 412-425 41 Kosmider S, Tan TH, Yip D et al. Radioembolization in combination with systemic chemotherapy as first-line therapy for liver metastases from colorectal cancer. J Vasc Interv Radiol 2011; 22: 780-786 42 Gray B, Van Hazel G, Hope M et al. Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol 2001; 12: 1711-1720 43 Smits ML, Prince JF, Rosenbaum CE et al. Intra-arterial radioembolization of breast cancer liver metastases: a structured review. Eur J Pharmacol 2013; 709: 37-42
